If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

Share Price is delayed by 15 minutes
Get Live Data
5,170.00    30.00 (0.58%)
Bid:
5,160.00
Ask:
5,165.00
Spread: 5.00 (0.097%)
Market Cap: £18.84b
CCH Live PriceLast checked at - London Stock Exchange

Intraday Coca-Cola HBC Share Chart

INVITATION TO PURCHASE NOTES FOR CASH

10 Mar 2016 10:09

RNS Number : 6828R
Coca-Cola HBC Finance B.V.
10 March 2016
 

NOT FOR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE U.S. VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS), ANY STATE OF THE UNITED STATES OR THE DISTRICT OF COLUMBIA OR TO ANY U.S. PERSON.

10 March 2016

COCA-COLA HBC FINANCE B.V. INVITATION TO PURCHASE NOTES FOR CASH: ANNOUNCEMENT OF RESULTS

On 3 March 2016, Coca-Cola HBC Finance B.V. (the "Company") launched an invitation to holders of its €600,000,000 4.250 per cent. Notes due 2016 guaranteed by Coca-Cola HBC Holdings B.V. and Coca-Cola HBC AG (the "Notes") to tender such Notes for purchase by the Company (the "Offer"), subject to applicable offer and distribution restrictions.

The Company today announces that it will (subject to satisfaction or waiver of the New Financing Condition) accept for purchase in cash an aggregate nominal amount of Notes validly tendered pursuant to the Offer equal to €214,619,000. The Purchase Price will be 102.903 per cent. of the nominal amount of the Notes. The Company will also pay an Accrued Interest Payment equal to 1.347 per cent. of the nominal amount of the Notes. A summary is set out below:

Description of the Notes

ISIN

Aggregate Nominal Amount Accepted for Purchase

Purchase Yield

Purchase Price

€600,000,000 4.250 per cent. Notes due 2016 of Coca-Cola HBC Finance B.V.

XS0466300257

€214,619,000

0.00 per cent.

102.903 per cent.

The Offer remains subject to the conditions and restrictions set out in a tender offer memorandum dated 3 March 2016 (the "Tender Offer Memorandum"). Capitalised terms used and not otherwise defined in this announcement have the meanings given in the Tender Offer Memorandum.

Subject to satisfaction of the New Financing Conditions, the expected Settlement Date for the Offer is 11 March 2016.

For Further Information

A complete description of the terms and conditions of the Offer is set out in the Tender Offer Memorandum. Further details about the transaction can be obtained from:

The Dealer Managers

Credit Suisse Securities (Europe) Limited

One Cabot Square

Canary Wharf

London E14 4QJ

United Kingdom

Telephone: +44 20 7883 8763

Attention: Liability Management Group

Email: liability.management@credit-suisse.com

 

 

Deutsche Bank AG, London Branch

Winchester House

1 Great Winchester Street

London EC2N 2DB

United Kingdom

Telephone: +44 20 7545 8011

Attention: Liability Management Group

Email: liability.management@db.com

 

Société Générale

10 Bishops Square

London E1 6EG

United Kingdom

 

Telephone: +44 20 7676 7579

Attention: Liability Management

Email: liability.management@sgcib.com

 

The Tender Agent

 

Lucid Issuer Services Limited

Tankerton Works

12 Argyle Walk

London WC1H 8HA

United Kingdom

Telephone: +44 20 7704 0880

Attention: Thomas Choquet

Email: cchbc@lucid-is.com

A copy of the Tender Offer Memorandum is available to eligible persons upon request from the Tender Agent.

DISCLAIMER

The Dealer Managers do not take responsibility for the contents of this announcement. This announcement must be read in conjunction with the Tender Offer Memorandum. No offer to acquire any Notes is being made pursuant to this announcement.

The distribution of this announcement and the Tender Offer Memorandum in certain jurisdictions may be restricted by law. Persons into whose possession this announcement and/or the Tender Offer Memorandum come into are required by each of the Company, the Guarantors, the Dealer Managers and the Tender Agent to inform themselves about and to observe any such restrictions.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGMGMFGGKGVZM
Date   Source Headline
8th Feb 20212:44 pmRNSNotice of Results-New time for the analysts call
19th Jan 20212:42 pmRNSDirector/PDMR Shareholding
18th Jan 202112:26 pmRNSNotice of Results
7th Jan 202110:29 amRNSAthens Exchange trading date of ordinary shares
18th Dec 20201:56 pmRNSDirector/PDMR Shareholding
1st Dec 202011:21 amRNSIssue of equity and total voting rights
19th Nov 20203:44 pmRNSPublication of Suppl.Prospcts
18th Nov 20202:23 pmRNSDirector/PDMR Shareholding
11th Nov 20207:00 amRNSSTRONGLY IMPROVED TRADING IN Q3
2nd Nov 20209:07 amRNSIssue of equity and total voting rights
21st Oct 20205:00 pmRNSAppointment of Chief Financial Officer
19th Oct 20202:26 pmRNSDirector/PDMR Shareholding
12th Oct 202012:44 pmRNSNotice of Results
25th Sep 202010:09 amRNSDirector Declaration
18th Sep 20201:31 pmRNSDirector/PDMR Shareholding
9th Sep 20204:24 pmRNSPublication of Suppl.Prospcts
1st Sep 202010:31 amRNSIssue of equity and total voting rights
18th Aug 202012:28 pmRNSDirector/PDMR Shareholding
13th Aug 20205:08 pmRNSDirector Declaration
7th Aug 202010:54 amRNSDirector/PDMR Shareholding
5th Aug 20207:00 amRNSENCOURAGING SIGNS AS MARKETS REOPEN
4th Aug 20203:05 pmRNSDirector/PDMR Shareholding
3rd Aug 20209:01 amRNSTotal Voting Rights
31st Jul 20202:46 pmRNSNotice of Results-New time for the analysts call
20th Jul 20203:19 pmRNSDirector/PDMR Shareholding
9th Jul 20203:03 pmRNSNotice of Results
7th Jul 20204:45 pmRNSCCH names Naya Kalogeraki Chief Operating Officer
1st Jul 202010:09 amRNSTotal Voting Rights
30th Jun 202011:21 amRNSDirector/PDMR Shareholding
25th Jun 20203:38 pmRNSDirector/PDMR Shareholding
18th Jun 20202:35 pmRNSDirector/PDMR Shareholding
18th Jun 20207:42 amRNSCFO to step down in the first quarter of 2021
16th Jun 20203:54 pmRNSDirector/PDMR Shareholding
16th Jun 20201:42 pmRNSComposition of the Committees of the BoD
16th Jun 20201:06 pmRNSResult of AGM
12th Jun 20201:59 pmRNSAthens Exchange trading date of ordinary shares
9th Jun 20209:40 amRNSDirector/PDMR Shareholding
19th May 20201:08 pmRNSDirector/PDMR Shareholding
14th May 20207:00 amRNSAGM notice, changes to the BoD and dividend dates
11th May 20205:39 pmRNSPublication of Suppl.Prospcts
7th May 20207:00 amRNSKEEPING OUR PEOPLE SAFE AND CUSTOMERS SERVED
1st May 202010:36 amRNSBlock listing Interim Review
30th Apr 20204:13 pmRNSDirector/PDMR Shareholding
30th Apr 20203:59 pmRNSPublication of a Prospectus
27th Apr 20205:42 pmRNSDisclosure of Rights attached to Equity Shares
21st Apr 20201:00 pmRNSDirector/PDMR Shareholding
14th Apr 20203:33 pmRNSNotice of Results
9th Apr 20205:45 pmRNSTotal Voting Rights - Replacement
9th Apr 20205:18 pmRNSTotal Voting Rights
27th Mar 20201:10 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.